Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial

Journal of Affective Disorders

Volumn 58, Issue 3, 2000, Pages 201-209

  Guelfi, J D ^a   Strub, N ^b   Loft, H ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b H LUNDBECK A S   (Denmark)

Author keywords

Citalopram infusion; Citalopram tablet; Phase III trial; Severe depression

Indexed keywords

CITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INFUSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; TABLET; TREMOR;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0034009783     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00120-2     Document Type: Article

References (25)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, D.C.
2. Baumann P., Larsen F. The pharmacokinetics of citalopram. Rev. Contemp. Pharmacother. 6:1995;287-295.
3. Baumann P., Nil R., Bertschy G., Jecker A., Brandli J., Morand J., Kasas A., Vuagniaux O., Ramseier. A double-blind double dummy study of citalopram comparing infusion versus oral administration. J. Affect. Disord. 49:1998;203-210.
4. Bouchard J.-M., Strub N., Nil R. Citalopram and viloxazine in the treatment of depression by means of slow drop infusion. A double-blind comparative trial. J. Affect. Disord. 46:1997;51-58.
5. Bouchard J.M., Delaunay J., Delisle J.P., Grasset N., Mermberg P.F., Molczadzki M., Pagot R., Richou H., Robert G., Ropert R., et al. Citalopram versus maprotiline: a controlled, clinical multicentre trial in depressed patients. Acta Psychiatr. Scand. 76:1987;583-592.
6. Charbonnier J.-F., Reboul P., Rougier M., Aubin B., Chassaing J.L., Philippe P., Hopfner Petersen H.E. Étude ouverte d'un inhibiteur très sélectif du captage de la sérotonine administré en perfusion à des patients déprimés. Encéphale. 13:1987;249-254.
7. Derogatis L.R. SCL-90-R (revised) Version Manual I. 1977;Clinical Psychometrics Research Unit, John Hopkins University School of Medicine, Baltimore, Maryland.
8. EEC/GCP guidance notes, 1991.
9. Ekselius L., von Knorring L., Eberhard G. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice. Int. Clin. Psychopharmacol. 12:1997;323-331.
10. French Huriet Law, 1988.
11. Gastpar M., Gilsdorf U., Baumann P. Comparison of oral and intravenous treatment of depressive states: preliminary results of a WHO collaborative study. Clin. Neuropharmacol. 9:1986;434-436.
12. Glassman A.H., Bigger J.T. Jr. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch. Gen. Psychiatry. 38:1981;815-820.
13. Guidance III/3976/88-EN 'Good Clinical Practice (GCP) for Trials on Medicinal Products in the European Community'. Pharmacol. Toxicol. 67, 361-372.
14. Guy W. ECDEU Assessment Manual for Psychopharmacology. 1976;US Dept. Health, Education and Welfare, Rockville, MD. revised 1976.
15. Haffmans, P.M.J., Timmerman, L., Hoogduin, C.A.L., the LUCIFER Group, 1996. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. Int. Clin. Psychopharmacol. 11, 157-164.
16. Jungkunz G., Kuss H.J., Dieterle D. Vergleich der Infusionsbehandlung mit der peroralen Applikation von Clomipramin bei endogen depressiven Patienten. Kielholz P., Adams C. Tropfinfusionen in der Depressionsbehandlung. 1984;Thieme, Stuttgart.
17. Kissling W., Möller H.J., Lauter H., Binz U., Wendt G. Double-blind comparison of intravenous versus oral maprotiline. Antidepressant activity, plasma levels, side effects. Pharmacopsychiatry. 15:1985;96-97.
18. Laux, G., König, W., Baumann, P., 1997. Infusionstherapie bei Depressionen: Ein Leitfaden fur Klinik und Praxis. 4. Aufl., Hippokrates Verlag, Stuttgart.
19. Laux G., König W., Lesch K.P., Stein A. Intravenöse versus orale Behandlung endogen depressiver Patienten mit Doxepin-Eine Doppel-blindstudie mit Plasmaspiegelbestimmungen. Wien Med. Wochenschr. 139:1989;525-529.
20. Montgomery S.A., Rasmussen J.C.G., Lyby K., Connor P., Tanghoj P. Dose response relationship of citalopram 20 mg, citalopram 40 mg and placebo in the treatment of moderate and severe depression. Int. Clin. Psychopharmacol. 6:1992;65-70.
21. Noble S., Benfield P. Citalopram a review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs Nov. 8:1997;410-432.
22. Pariente P., Lépine J.P., Boulenger P.H., Zarifian E., Lemperiere T.H., Lellouch J. The symptom check-list 90-R (SCL-90-R) in a French general psychiatric 708 outpatient sample. Is there a factor structure? Psychiatr. Psychobiol. 4:1989;151-157.
23. Patris M., Bouchard J.M., Bougerol T., Charbonnier J.F., Chevalier J.F., Clerc G., Cyran C., Van Amerongen P., Lemming O., Hopfner-Petersen H.E. Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. Int. Clin. Psychopharmacol. 11:1996;129-136.
24. Van Praag H.M., Korf J., Schut T. Cerebral monoamines and depression. Arch. Gen. Psychiatry. 28:1973;827-831.
25. Williams R.B. Jr., Sherter C. Cardiac complications of tricyclic antidepressant therapy. Ann. Intern. Med. 74:1971;395-398.